Navigation Links
LabCorp(R) and Vanda Pharmaceuticals Collaborate to Offer Genetic Tests
Date:6/5/2008

BURLINGTON, N.C. and ROCKVILLE, M.D., June 5 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH), one of the world's leading clinical trials and genetic testing laboratories, and Vanda Pharmaceuticals Inc. (Nasdaq: VNDA), a biopharmaceutical company focused on the development and commercialization of clinical-stage product candidates for central nervous system disorders, today announced an exclusive alliance to develop and commercialize a series of diagnostic tests for genetic markers identified by Vanda in the course of its clinical development of Fanapta(TM) (iloperidone), a novel atypical antipsychotic drug candidate under FDA review for the treatment of schizophrenia. Financial terms of the agreement were not disclosed.

Vanda has identified a series of pharmacogenetic markers during its development of Fanapta(TM), and the company continues its pioneering work in this area. Under the terms of the collaboration, LabCorp will be Vanda's exclusive commercialization partner for tests for genetic markers of the Fanapta(TM) program.

"Working with innovative companies like Vanda to commercialize predictive medicine tests is a critical strategic focus for LabCorp," said Andrew J. Conrad, Ph.D., Chief Scientist and Global Head of Clinical Trials for LabCorp. "This collaboration is an example of our commitment to the advancement of personalized medicine and represents a successful translation of a research based assay into a valuable diagnostic test. This relationship i
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results
2. Vanda Pharmaceuticals to Present at the Bank of America 2008 Healthcare Conference
3. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
4. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
7. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
8. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
9. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
10. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
11. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...URHAM, N.C., Nov. 25 Research Tria...rgy-efficient, single-treatment water purification...es to Andhra Pradesh, Minister of Rural Water Supp...derabad, India today. Initial tests, performed at ...rmed that the majority of the drinking water avail...
(Date:11/25/2009)... BEIJING, Nov. 25 /PRNewswire-Asia/ -- Sinovac ...der of vaccines, announced today that it executed,...c (Dalian) Vaccine,Technology Co., Ltd. (Sinovac D... commercialize human-use vaccines. Sinovac will co...g and commercializing world-class vaccines; the,ot...
(Date:11/24/2009)... Ambassador to also Visit Detroit , ...,Who: David Appia, French Ambassador for Internati...t in France Agency, , , , ,What: Ambassador Appia... pro-business initiatives adopted by France to fur...ndscape for innovation and development., , ,When: ...
(Date:11/24/2009)...LOUIS, Nov. 24 Sigma-Ald...ng at the NASDAQ OMX conference on Tuesday, Decemb...nterested parties may listen via live audio broadc...s tor.sig m a a ldrich.com/ . Users can cli... About Sigma-Aldrich: Sigma-Aldrich is a leadi...
Breaking Biology Technology:North Carolina-based Cnanoz Unveils NanoPure(TM) to Government Leaders in Hyderabad, India 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3
...y., Feb. 20 Bariatric surgeons at Central,Baptist...forming a,groundbreaking bariatric procedure to de... making a single incision into her body. This is t...med in the United States. , Bariatric surgeon ...ed,POSE (Primary Obesity Surgery, Endoscopy). Dr. ...
... 341st Consecutive Quarterly Dividend , , ABBOTT...bbott ( NYSE: ABT ) today increased the company,s ...er share. , , This marks the 37th consecutive ye...nd the 341st consecutive quarterly dividend to be ...ayable May 15, 2009, to shareholders of record at ...
...bruary 20 Authentic Natural and Organic,Cosmetic*...to the NaTrue,Label: the first 100 products have a... The NaTrue-Label provides orientation for consu...nt and strict criteria for Natural and Organic,Cos...to all manufacturers and,guarantees independent ce...
Other Biology Technology:Surgeons Perform First Incisionless Bariatric Procedure in the United States 2NaTrue-Label: The First 100 Products are Certified 2
(Date:11/23/2009)...y by the Wildlife Conservation Society says that w... the Republic of Congopart of the "mother lode" of...e becoming increasingly threatened by growing huma...s protection of the swamp forests adjacent to the ... recent surveys confirmed that high densities of t...
(Date:11/23/2009)...CT Current research suggests that a common oral b...elated report by Nichols et al, "Unique Lipids fro...f TLR2 Ligands Capable of Enhancing Autoimmunity,"...an Journal of Pathology . , Multiple sclerosis (... brain and spinal cord, affects nearly 1 in 700 pe...
(Date:11/23/2009)... - The only swine vaccine available for the H1N1 v...ted with the virus. The vaccination marks the firs...osed with the pandemic flu., Iowa State Universi...eloped the vaccine this summer and has been shippi...nsas and Illinois for several weeks., The latest...
Breaking Biology News(10 mins):A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Factors from common human bacteria may trigger multiple sclerosis 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Genetics of patterning the cerebral cortex 59356 1Genetics of patterning the cerebral cortex 59356 2Genetics of patterning the cerebral cortex 59356 3A new scan for lung diseases 59354 1A new scan for lung diseases 59354 2Canadian blood supply future uncertain as population ages 3A Study 59352 1Canadian blood supply future uncertain as population ages 3A Study 59352 2
...chool researchers have discovered one way that a h...n the lungs of chronically infected cystic fibrosi...se pathogenic bacteria such as Pseudomonas aerugin...sease in their hosts," said Joseph Mougous, lead a...f Science. "In the case of Pseudomonas aeruginosa,...
...be able to change their spots, but corals can chan... minerals depending on the chemical composition of...conclusion drawn by a Johns Hopkins University mar...urnal Geology. , Postdoctoral fellow Justin Ries... case of an animal altering the composition of its...
...r brightly coloured males because they are easier ...earcher Martine Maan following her study of fish s... variation subsequently leads to differences in pr...nary theory predicts that species can diverge if d...in males. Yet females often pay attention to trait...
Other Biology News:Discovery could aid fight against cystic fibrosis infection 2Corals switch skeleton material as seawater changes 2Corals switch skeleton material as seawater changes 3Choosy females make colourful males 2
BD BioCoat Osteologic 12 mm round Coverslips from BD Biosciences - Discovery Labware
...tibiotic that inhibits N-linked glycosylation and ...hydrate linkages. Active in vitro against Gram-p...bits the expression of functional thrombin recepto...thrombin-induced Ca 2+ mobilization in cells. Pu...
...s used for agitation and mixing applications such ...ng and destaining of gels and blots, and Southern ...control (8-40 rpm) and can handle a maximum load o...cm platforms covered with nonsolid rubber mats tha...
Mouse Anti-Human DCAMKL2 Monoclonal Antibody, Unconjugated, Clone 2A5 from Novus Biologicals
Biology Products: